ATOXOPLASMA
MEDICAL PROTOCOLS RECOMMENDED BY THE PASSERINE ATOXOPLASMA WORKING GROUP
Terry M. Norton, DVM, Dipl. ACZM1,
Donald L. Neiffer, VMD2, Bob Seibels9, Keith Benson, DVM9, Denise
McAloose, VMD, Dipl. ACVP6, Dominic Travis, DVM, MS10, Ellis Greiner, PhD3, Kenneth
Latimer, DVM, PhD4, Dipl. ACVP, Susan E. Little, DVM, PhD5,
Jacqueline M. Zdziarski, DVM7, Mark Schrenzel, DVM, PhD, Dipl. ACVP8,
Bruce Rideout, DVM, PhD, Dipl. ACVP8, Martin Vince9,
Ned Gentz, DVM, Dipl. ACZM11
1Wildlife Conservation
Society, St. Catherine Island Wildlife Survival
Center,
182
Camelia Road, Midway, GA 31320, Ph: 912-884-5005, Fax: 912-884-5007,
Email: tnmynahvet@aol.com
or tnorton@wcs.org
2Disney’s Animal Programs
P.O. Box
10,000, Lake Buena Vista, Florida 32830, Ph: 407-938-2719, Fax: 407-939-6391,
Email: Donald.Neiffer@disney.com
3University of Florida, Department of Pathobiology, College of
Veterinary Medicine, 2015 SW 16th Ave, Building 1017, Rm V3-240,
Gainesville, Florida 32610, Ph: 352-392-4700 ext. 5861, Fax: 352-392-8351,
E-mail: greinere@mail.vetmed.ufl.edu
4University of Georgia, College of Veterinary Medicine, Department
of Pathology, Athens, GA 30602, Ph: 706-542-5844, Fax: 706-542-5828, Email: latimer@calc.vet.uga.edu;
5Department of Medical Microbiology and Parasitology,
College of Veterinary Medicine, The University of Georgia, Athens, Georgia
30602, Ph: 706-542-8447,
Fax:
706-542-0059, Email: slittle@calc.vet.uga.edu
6Wildlife Conservation Society/Bronx Zoo, Department of Pathology,
2300 Southern Boulevard, Bronx, NY 10460-1090, Email: dmcaloose@wcs.org
7Brookfield Zoo/Chicago Zoological Society, Department of Animal
Health, 3300 Golf Road, Brookfield, IL 60513 1095, Email: jazdziar@brookfieldzoo.org,
Ph: 708-485-0262 ext. 504
8San Diego Zoo, Department of Pathology, 2920 Zoo Drive, San Diego,
CA 92101, Email: brideout@sandiegozoo.org
9Riverbanks Zoo and Botanical Garden, 500 Wildlife Parkway,
Columbia, SC 29210, kbenson@riverbanks.org, bseibels@riverbanks.org,
mvince@riverbanks.org
10Davee Center for Veterinary Epidemiology, Lincoln Park Zoo, 2001
N. Clark St., Chicago, IL 60614, 312-742-7225 epi@lpzoo.org
11Albuquerque Biological Park, 903 10th Street SW, Albuquerque,
NM 87102-4029, Email: ngentz@cabq.gov,
Ph: 505-764-6261.
INTRODUCTION
The following document is the edited output from a workshop on Atoxoplasma held at the Eastern Regional AZA conference in Columbia, SC on March 27, 2003. Participants included a panel of veterinarians, researchers, and avian curators, each of whom gave a presentation focusing on a particular aspect of the organism: etiology; diagnosis; treatment; and implications for captive avian management programs. The stated goal of the workshop was to produce a “white paper” summarizing the most current information available on Atoxoplasma. It is the hope of the authors that this document will encourage both veterinarians and curators in North America to establish protocols with some measure of consistency to deal with what is now generally recognized as a ubiquitous disease.
Atoxoplasma constitutes an extremely difficult and controversial parasitic pathogen to manage in captive passerine birds. Currently, zoological institutions manage this parasite in a variety of ways, making it difficult to conduct long term reproduction and conservation programs in passerine bird species. The following recommendations and information represent an effort to bring some consistency to the management of Atoxoplasma in passerine bird species. Each institution should have a management team in place to evaluate the risks and benefits of bringing Atoxoplasma-positive birds into the collection. Treatment protocols discussed have been successful in managing Atoxoplasma in a variety of passerine species. Please refer to http://www.riverbanks.org/subsite/aig/baliopen.htm for more detailed information on atoxoplasmosis.
RECOMMENDATIONS
FOR ATOXOPLASMA MANAGEMENT IN PASSERINE BIRDS
I. General comments
1. Any zoological institution housing passerines in the typical manner (natural substrates, planted enclosures, mixed species) probably should be considered to have Atoxoplasma in their collection. Although facilities may claim to be “Atoxoplasma free”, the more likely explanation is that effective screening for the organism has not been performed.
2. Atoxoplasma is present in all outside aviaries.
3. All parent-reared passerines should be considered to have been exposed to an Atoxoplasma contaminated environment whether captive hatched or wild-caught.
4. Indoor enclosures that have housed passerines (other than hand-reared passerines as described below) and have not been disinfected, including removal of substrate, are considered to be Atoxoplasma contaminated.
1.
While the organism may be
species specific, interspecies transmission certainly occurs.
2. There is concern that free-ranging North American passerine birds may be infecting some captive specimens housed outdoors.
3. Pilot Study: Comparative measurements of the oocysts of superb starling (Spreo superbus) and Bali mynah Atoxoplasma revealed that the superb starling oocysts were slightly smaller. A pilot study (Norton and Greiner, unpublished data) was conducted with 1 superb starling as a control bird and 1 superb starling as an experimental bird at North Carolina Zoological Park. The experimental bird was given the Bali mynah Atoxoplasma oocysts by gavage. The oocysts essentially passed through the gastrointestinal tract but did not disseminate to other parts of the body. Dexamethasone was given to the bird to cause immunosuppression and it was rechallenged, but the organism still just passed through the gastrointestinal tract and was not detected on serial buffy coat smears.
4. Further interspecies transmission studies are needed, with larger numbers of birds and more species, in order to gain more insight into the species specificity of this organism.
5.
Species
documented with Atoxoplasma (See Appendices and references for further information):
a.
UGA Study: Amakihi, Apapane, Bali mynah, black-headed
weaver, blue dacnis, blue-faced honeyeater, canary, fairy bluebird, golden
crested mynah, honeycreepers (purple, red-legged), liwi, house sparrow,
Montezuma oropendula, starling (emerald, golden breasted, superb), tanagers (blue
gray, green and gold, paradise, rufous-crowned, scarlet rumped, silver beaked,
turquoise), violaceous euphonia.
b.
Brookfield Zoo Study: 18 tanager species (9
Genera) were included in this study
c.
Disney Study: golden-breasted starling and golden
crested mynah
d. Greiner’s Study: Sturnidae: Bali mynah, superb starling, gold breasted starlings, gold crested mynah, Indian hill mynah; Timaliidae: black-throated laughing thrush, yellow-throated laughing thrush; Ploceidae: black-headed weaver; Troglodytidae: cactus wren; Thraupidae: silver-beaked tanager; Pittidae: hooded pitta
6. Species-specific susceptibility to the organism
i. There are probably numerous other examples of morbidity and mortality variability in closely related passerine species.
ii. One example of species variation in susceptibility has been noted by the staff at Disney’s Animal Kingdom. Golden-breasted starlings have experienced mortality from the organism, whereas the golden crested mynah have not.
1. The effect of atoxoplasmosis on a given collection depends on the species housed; reproductive efforts/programs for the particular species; facility design and maintenance; and enclosure location (indoor or outdoor). Consequently, no two institutions should be expected to have identical plans or protocols for managing Atoxoplasma.
2. Discussions should occur between husbandry and veterinary departments regarding risks and benefits of reproductive programs and species exhibition versus potential Atoxoplasma infection.
3. Responsibility for the management of Atoxoplasma should be shared by both the husbandry and veterinary teams.
4. All protocols and management plans for Atoxoplasma should be re-evaluated regularly.
5. Increased Atoxoplasma-associated mortality or morbidity in a newly-acquired or reproducing species should prompt an immediate re-evaluation of protocols to address the situation.
Questions to be
considered when bringing a passerine species or individual bird into a
collection for breeding
1. What is the species’ susceptibility to clinical atoxoplasmosis?
2. Are the birds considered exposed to Atoxoplasma?
3. Has Atoxoplasma-associated mortality been documented at the sending institution? In the species of concern?
4. If the answer is no, what type of screening for the disease occurs at the sending institution?
5. Has
this species been maintained previously at the receiving institution? Has there
been Atoxoplasma-associated disease
in adults and/or chicks/fledglings at this institution?
6. Receiving institution: for species deemed highly susceptible to clinical atoxoplasmosis, can modifications be made to the current aviary management system that would reduce risk to acceptable levels? Note: in situations where infection causes 100% mortality at a particular institution, acquisition may not be acceptable under any situation. Certain species may be deemed highly susceptible under the current aviary management system at the receiving institution. These species may not be accepted for that reason.
·
One tool available for assessing disease
processes on captive populations is the electronic records system, MedARKS.
However, in order for the information to be easily searchable, it would be
advantageous to identify MedARKS records with
studbook or ARKS identifiers. Without
this information in the medical record, it is difficult to formulate an
animal’s life history across institutions.
Example of application: Currently, a review of the historic medical records of over 500 Bali mynahs is under way. Publications are being planned to both 1) summarize the clinical signs and health parameters associated and not associated with atoxoplasmosis, and 2) relate the medical information to that found in the studbook in order to determine the effects of this parasite on the entire population, including chick and adult mortality and survival rates. This project should be finished at the end of 2004. This study has been greatly delayed by the effort required to match both paper and electronic records from birds across both time and multiple institutions.
1. Oocysts
are not always present in feces of clinically affected birds.
2. If
Isospora-like coccidia are found in
the feces of a Bali mynah, it is most likely Atoxoplasma. Hundreds of fecal samples have been performed on Bali
mynahs and on only 2 occasions has another species of coccidia been observed.
3. The
oocysts of Isospora and Atoxoplasma cannot be distinguished from
each other via light microscopy. Both have 2 sporocysts each with 4
sporozoites. Systemic stages must be identified to confirm that the passerine
bird is infected with Atoxoplasma.
4. To
definitively rule out fecal shedding, feces should be collected over several
days and placed in 3-5% potassium dichromate (PDC). Periodic aeration of the
PDC and feces allows the organism to sporulate in approximately 96 hours thus
enhancing identification. Pooled fecal
samples over 24 hrs or multiple fecal exams are alternatives methods to rule
out fecal shedding.
5. A
definitive diagnosis of atoxoplasmosis cannot be made only by performing a
fecal examination and finding Isospora sp. This is an important part of
the diagnostic workup, but needs to be combined with other diagnostic tests
listed below for a definitive diagnosis.
1. Atoxoplasma can be found on blood smears in mononuclear cells.
2. Buffy coat smears concentrate the white blood cells, thus increasing the likelihood of finding the organism when compared to routine blood smears. Unfortunately, making buffy coat smears is an art, thus always submit a normal blood smear with the buffy coat smears for insurance.
3. Only a very small percentage of adult Bali mynahs shedding oocysts in the feces have been positive on buffy coat smear evaluations.
4. Positive buffy coat smears are much more common in juvenile birds with clinical signs of atoxoplasmosis (Partington et al., 1989).
5. Multiple buffy coat smears are recommended to
rule out atoxoplasmosis in symptomatic birds.
6. See Appendix 1 for Greiner unpublished information on correlations between buffy coat smears and fecal samples for positive diagnosis of oocysts and systemic stages of Atoxoplasma.
1)
Advantages of assay
·
Can be applied to multiple
sample types including whole blood, feces, and tissue although usefulness
depends on disease status, species affected, and sample type being tested.
·
Aids in diagnosis of cases where clinical signs or
microscopic lesions are suggestive of Atoxoplasma but organisms are not
observed.
·
Potential application in evaluating efficacy of
chemotherapeutic protocols and husbandry practices designed to reduce incidence
of infection.
·
Provides data to further evaluate species-specificity
and diversity of Atoxoplasma spp.
·
Useful as a screening test for determining
incidence/prevalence of atoxoplasmosis in a particular species or collection.
·
Useful in evaluating breeding individuals for the
purpose of assessing need for prophylactic
treatment during brooding or for consideration of pulling eggs for hand-rearing
chicks.
2)
Limitations of
assay
·
Only confirms presence of organism - cannot be used to
identify Atoxoplasma-free birds.
·
The commercially available UGA PCR has the potential to
detect other Isospora spp. The San Diego Zoo PCR test will not confuse Atoxoplasma
with Isospora. They are genetically
distinct.
· Especially problematic in fecal samples based on experience by the UGA research group.
q Sensitivity in fecal sample is poor.
q Oocysts
must be present to successfully amplify.
q Occasional
failure of amplification in the presence of oocysts on fecal flotation
including clinical cases with disseminated atoxoplasmosis.
3)
See Appendix 2 for summaries of recent or ongoing Atoxoplasma PCR
studies and UGA Atoxoplasma PCR sample submission protocol.
1)
Cytology may be
more reliable than histopathology for detecting the circulating stages. Histopathology is very good at picking up
the intestinal stages.
2)
Liver and
spleen are preferred samples for detecting circulating stages of the organism.
1.
Atoxoplasmosis can be diagnosed by histopathology.
2.
Given the typical small size of biopsies taken in avian
species along with the multifocal distribution of hepatic lesions associated
with Atoxoplasma infection,
histopathology may only reveal normal hepatic tissue, resulting in a false negative
diagnosis.
3.
Hepatic pathology associated with Atoxoplasma infection often includes lymphohistiocytic and
heterophilic hepatitis. However, this type of lesion can be seen with other
etiologic agents. Consequently, the presence of this type of lesion without
observable Atoxoplasma organisms does
not represent a positive diagnosis of atoxoplasmosis.
1. Most common gross pathological findings are an enlarged
liver and spleen with pinpoint foci of necrosis, an edematous pancreas, and a
fluid filled intestinal tract.
2. In the majority of birds, histopathology reveals
inflammatory foci (most commonly in the liver, spleen, and lung) with
intracytoplasmic zoites. In addition,
atypical lymphoid or other proliferative lesions (possible neoplastic
processes) are seen in association with the organism in a few species.
3. Many other organs may be involved.
4. A thorough necropsy should be performed on passerine birds
that die.
5. Recommendations for necropsy: collect a small section of all
major tissues (heart, lung, airsac (on a piece of paper towel), thymus, bursa,
crop, proventriculus, multiple sections of intestine, pancreas, kidney, adrenal
gland, gonad, oviduct, muscle, bone marrow, and brain) in 10% buffered
formalin. Impression smears of liver and spleen should be made after gently
blotting cut surface on a paper towel and fixed.liver and spleen.
A definitive diagnosis of
atoxoplasmosis can only be made by directly visualizing the organism on buffy coat
smears, cytological, or histopathological specimens. However, the San Diego Zoo pathologists have seen unusual
morphologic manifestations of atoxoplasmosis that could only be definitively
diagnosed by PCR.
A. Sufachlorpyrazine (ESB3)
§ Has been successful in reducing mortality from Atoxoplasma in canaries and Bali mynahs.
§ Sulfachlorpyrazine in the water has significantly reduced or totally cleared fecal oocyst shedding for an extended period of time in Bali mynahs. If fecal shedding is inhibited, chick mortality will be decreased or eliminated.
§ It is unlikely that drug can completely clear a bird of Atoxoplasma.
§
Sulfachlorpyrazine only
affects the intestinal stages of the parasite.
§
The treatment regimen using sulfachlorpyrazine in the
Bali mynah and several other passerine bird species shedding the organism and
long term prevention is as follows: mix 1 gram of the 30% powder in 1 liter of
water and use this as the only source of drinking water for 5 days; no drug for
3 days; then repeat the 5 day treatment; this cycle is repeated 4 times,
constituting one treatment. The birds should be treated three times per year if
possible. Important times to schedule preventive treatments are during the
breeding season and when parents are feeding chicks through fledging. A vitamin
supplement containing vitamin B6 should be utilized during the treatment
period. If the regular diet already contains adequate levels of vitamin B6 then
this may not be necessary.
B. Vetisulid (sulfachlorpyridazine) can be used as a replacement for sulfachlorpyrazine
(ESB3), which is not available in the US.
The dose used is 300 mg/liter of water.
Follow the same general protocol and frequency as ESB3.
§
Recent study using Vetisulid
treatment in one sturnid species Golden-breasted starling (Cosmopsarus regius)) at Disney (D. Neiffer)
1.
Treatment parameters
a. Dosed at 300 mg/L water
b. Treated water was sole source on treatment days.
c. Treatment period lasted 32 days.
d. Treatment period consisted of four cycles.
e. Each cycle consisted of 5 days of treatment followed by 3
days without.
f.
Birds pre-tested 1-5 days
before treatment and re-tested 5-7 days after last treatment day.
2.
Results
a. 2/5 birds positive by buffy coat pre-treatment, 0/5 positive by buffy coat post-treatment.
b. 4/5 birds had Isospora oocysts both pre- and post-treatment. However, quantitative estimates changed from moderate-few oocysts pre-treatment to few-rare oocysts post-treatment
c. 2/2 birds were liver PCR positive both pre- and post-treatment.
d. 5/5 birds negative by PCR on whole blood (EDTA) pre- and post-treatment.
3.
Comments/conclusions:
a. PCR testing has limited, but potential use in evaluating success of treatment.
b. Birds that are liver PCR positive are not expected to convert to negative following treatment.
c. Even if treatment kills organisms, expect that DNA will
persist long term or forever.
d. This has ramifications for claims on treatment efficacy and Atoxoplasma status.
e. For birds that are blood PCR positive, conversion to negative blood PCR test following treatment may indicate clearance of circulating organisms (more diagnostic testing needs to be conducted on blood PCR positive individuals).
C. Toltrazaril (Baycox)
§ Baycox has been successful in reducing mortality from Atoxoplasma in canaries and several other passerine birds.
§ No published documentation that the birds were cleared of the organism and it is unlikely that drug can completely clear a bird of Atoxoplasma.
§
Toltrazuril appears to have some affect on systemic stages
of the disease (Dorrenstein, pers comm.).
It is currently approved in the US for use on Equine protozoal
myelitis.
§
Toltrazuril has
not been used extensively in the Bali mynah, but has been used in several other
passerine bird species. Further studies are needed using toltrazuril in a more
controlled manner to demonstrate its efficacy against systemic atoxoplasmosis.
D. Diclazuril has been effective in treating systemic avian toxoplasmosis and sarcocystis, and thus may have an effect on systemic atoxoplasmosis.
***Treatment minimizes shedding but is not a cure. It may actually be of benefit to have a mild infestation in order to stimulate the immune system. Birds that have not been exposed to the organism previously may be more susceptible to developing systemic disease. More clinical and controlled treatment trials are needed utilizing various available drugs to manage atoxoplasmosis.***
A. Husbandry practices are an extremely
important part of the management of this parasite.
B. Handrearing chicks to
prevent exposure to Atoxoplasma
1. Hand-rearing
may be a viable method of prevention under certain circumstances.
2. For
the purposes of this discussion, “hand-reared” refers to chicks hatched from
eggs that were pulled and cleaned for incubation prior to piping.
3. A
negative liver PCR test supports the Atoxoplasma-free
status in hand-reared chicks as long as they have been kept out of a
contaminated environment.
4.
A negative liver PCR
test in a parent-reared chick does not rule-out exposure as it is unknown how
long after infection with Atoxoplasma that a conversion to positive
liver PCR occurs.
5.
Concerns regarding hand-rearing and Atoxoplasma
c. More controlled studies are needed to evaluate this issue.
C. Diagnostic recommendations for preshipment
and quarantine:
Adult Birds
· CBC and chemistry panel with emphasis on liver values
· PE
· whole body x-ray
· fecal bacterial culture
· fecal exam for parasites
· Atoxoplasma diagnostics described above; treat if indicated or discuss situation with receiving institution so that treatment can be performed while bird is in quarantine
·
Unless liver biopsy with PCR is
performed with negative results and the bird is housed in sterile conditions
following biopsy, any claim of negative atoxoplasma status is highly
questionable
Fledgling chicks
· A neonatal examination is recommended shortly after fledging occurs, as the bird is being transferred to a new enclosure.
· The examination should include a body weight, a thorough physical exam, complete blood count, buffy coat smear for Atoxoplasma assessment, serum biochemistry panel (if possible), and fecal examination.
· If the fledgling bird appears unthrifty, the Atoxoplasma diagnostic protocol should be followed.
·
Regarding screening for Atoxoplasma infection in healthy
fledglings, if buffy coat exam is negative, then it is recommended to use liver
PCR testing (rather than fecal exam and blood (EDTA) PCR to confirm negative
status. If the buffy coat exam is positive then this confirms the positive Atoxoplasma status and in most birds is
less invasive than liver biopsy.
D. Birds being used for display
vs. a reproductive program:
1. Birds in large multi-species aviaries are generally difficult to treat on a regular basis in a stress free manner and it is usually best to use this situation for displaying birds rather than for intensive reproduction programs.
2. Passerine birds that are positive for Atoxoplasma and are in a breeding program will be easier to manage in smaller enclosures that can be periodically broken down and sanitized. Furthermore, it is much easier to treat these birds routinely in the drinking water with the various therapeutics that are currently available.
3.
The impact of subclinical infections are unknown, but
the following are some possible scenarios:
§
Decline in condition and increased disease
susceptibility
§
Negative impact on breeding success
§
Clinical disease in birds that are stressed, old, or
that become ill from other causes.
§
Transmission to juveniles
§
Mild infections may stimulate
the immune system and prevent systemic atoxoplasmosis.
Appendix 1—(Greiner);
Unpublished information on correlations between buffy coat smears and fecal
samples for positive diagnosis of oocysts and systemic stages of Atoxoplasma:
· Sturnidae: Bali mynah 397 positive in feces, 170 negative, 27 positive on buffy coat, 268 negative; superb starling: 47 positive on fecal, 13 negative, 5 positive on buffy coat and 20 negative; gold breasted starlings: 28 positive and 8 negative on feces, 5 positive on buffy coat and 20 negative; gold crested mynah: 1 positive on feces and 11 negative, 33 positive on buffy coat and 31 negative: Indian hill mynah: 0 positive on feces and 1 negative, buffy coat 1 positive and 0 negative.
· Timaliidae: Black-throated laughing thrush: 0 positive and 2 negative on feces, 4 positive and 3 negative on buffy coat; yellow-throated laughing thrush: 4 positive and 0 negative on feces, 4 positive and 9 negative on buffy coat.
· Ploceidae: Black-headed weaver: 1 positive on impression smear
· Troglodytidae: cactus wren: 4 positive and 0 negative on feces, 1 positive and 2 negative on buffy coat.
·
Thraupidae: silver-beaked tanager: 1 positive and 3 on
feces, 3 positive and 3 negative on buffy coat.
·
Pittidae: hooded pitta: no feces, 1 positive on buffy
coat.
Appendix 2-- Summaries of
recent or ongoing Atoxoplasma PCR studies and UGA Atoxoplasma PCR
sample submission protocol.
Introduction: The current knowledge of polymerase chain
reaction (PCR) diagnostics as it pertains to Atoxoplasmosa in passerine birds comes from efforts by researchers
at the San Diego Zoo and University of Georgia CVM.
Study 1: Information currently available from the San Diego Zoo Study
on necropsy specimens
Host species Range
· Fifty birds of 23 species were PCR positive.
· 47/50 had a postmortem diagnosis of atoxoplamosis.
· 27/50 had sexual stages in small intestine.
· 19/33 had positive postmortem lung/spleen smears.
· 6 birds of 4 species had isosporoid oocysts in the feces (less fecal samples were evaluated).
Molecular Characterization
· In most instances, each avian species had a unique genotype of the parasite. However, house sparrows were found to be infected only with the Bali mynah parasite, so they did not have their own unique genotype.
· Some species, and individuals within a species, had multiple genotypes (as determined from 16s and 23s rRNA gene sequences).
· 28 unique parasite genotypes were detected in the 23 avian species
Genetic Relationships
·
The average genetic distance between Atoxoplasma organisms is 2.19% (with a
std dev 0.937, max 4.946, min 0.414).
·
The closest genetic relative to Atoxoplasma in GenBank is Eimeria
tenella.
·
The average genetic distance (% difference in
nucleotides) between Atoxoplasma organisms in this study and E. tenella is 9.127%.
·
The parasites are therefore monophyletic (i.e. are more
closely related to each other than to any other parasite).
·
While each species of bird had a unique Atoxoplasma genotype,
different avian species sometimes had parasites that were very closely related
(99.6%).
·
These closely related genotypes could be substrains of
the same Atoxoplasma species.
·
The other genotypes that are 2-4.9% different, are
probably truly different species of Atoxoplasma.
Conclusions
· Atoxoplasma organisms in general appear to be host-specific. However, horizontal transmission between avian species has almost certainly occurred.
· It is possible that wild Northern house sparrows are transmitting Atoxoplasma to collection birds, however, transmission studies would be required to prove this.
· The blood forms (monocyte merozoites) of Atoxoplasma are genetically identical to the isosporoid oocysts seen in feces.
· No evidence for mite transmission has been found by PCR.
·
Some individual birds have parasite genotypes that differ
substantially enough to represent different species of Atoxoplasma.
Management implications
·
Horizontal transmission between different passerine
species probably occurs.
·
The risk of horizontal transmission between divergent
taxonomic groups of birds may occur based on the data from this study, but
appears to be less frequent and more unpredictable. Transmission studies are
still needed to confirm and investigate this issue further.
·
Wild sparrows may pose a risk to captive birds such as
Bali mynahs, but this risk is unpredictable and must be balanced against costs
and other risks. Further investigation is needed to confirm this.
Study 2: Information currently available from the University of Georgia
research group using PCR to identify Atoxoplasma spp.
PCR assay design
·
18s rDNA-----550 bp fragment-------424 bp fragment
·
Designed to amplify 18S rDNA fragment of Isospora spp.
· Used on systemic stages to amplify Atoxoplasma fragment.
PCR Assays on Clinical Samples
· 122 samples out of 303 were positive (40.3%)
o 192 blood/plasma samples with 61 positive (31.8%)
o 65 liver samples with 40 positive (61.5%)
o 46 other tissues with 21 positive (45.7%)
Species represented (refer to section 1. B. 5. for details)
Advantages of assay
·
Aids diagnosis in cases where clinical signs or
microscopic lesions are suggestive, but organisms not seen.
·
Potential application in evaluating efficacy of
chemotherapeutic protocols and husbandry practices designed to reduce incidence
of infection.
·
Provides data to further evaluate species- specificity
and diversity of Atoxoplasma spp.
·
PCR assay currently available on a fee-for-service
basis through diagnostic parasitology laboratory at UGA slittle@vet.uga.edu.
Limitations of assay
·
Potential to detect other Isospora spp is especially problematic in fecal samples.
·
Sensitivity in fecal samples poor
o
Oocysts must be present to successfully amplify.
o
Occasional failure of amplification even when oocysts are
present on fecal flotation.
· Only confirms presence of organism, cannot be used to identify Atoxoplasma-free birds.
Conclusion
·
PCR assay best suited to confirm suspected cases on
histopathology when organisms cannot be directly identified by microscopic
examination
Study 3: Atoxoplasmosis in Tanagers: Zdziarski, Adkesson, Little
o